Custirsen shows no benefit in combination with cabazitaxel in mCRPC

Early this morning, OncoGenex announced the result of final analysis of data from the Phase III AFFINITY trial of custirsen + cabazitaxel + prednisone in men with metastatic, castration-resistant prostate cancer (mCRPC) who had progressed after docetaxel chemotherapy. … READ MORE …

How closely do you feel connected to your doctors?

Your sitemaster has mentioned before that he likes to keep an eye on the blog by the medical oncologist Dr. Craig Hildreth on the CancerNetwork.com web site. … READ MORE …

Let’s call this “new technology” what it is; it’s a form of HIFU

According to information in the Boston Herald earlier today, researchers at Brigham & Women’s Hospital in Boston (one of the main teaching hospitals associated with Harvard University) are testing a new form of technology to treat localized prostate cancer. … READ MORE …

Selenium rising … all over again

As some of our older readers will remember, there was a major Phase III clinical trial several years ago (the SELECT trial) designed to study whether taking regular selenium supplements could help to lower risk for a diagnosis of prostate cancer. It didn’t. … READ MORE …

Howard Wolinsky’s continuing journey

Howard Wolinsky is a professional journalist who is being managed on active surveillance for a low-risk form of prostate cancer. He writes about this for MedPage Today. … READ MORE …

Alas, … the surgery vs. radiation therapy war continues …

In what certainly appears to be the largest and most thorough meta-analysis published to date, the authors conclude that surgery is a more effective first-line treatment for localized prostate cancer than radiation therapy. However, … READ MORE …

Is ADT giving you Alzheimer’s disease? … Another look

Late last year we reported on a study in the Journal of Clinical Oncology that suggested the possibility of a link between androgen deprivation therapy (ADT) and the onset of Alzheimer’s disease. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,455 other followers